Utility of 5-ALA for resection of CNS tumours other than high-grade gliomas: a protocol for a systematic review
Introduction 5-aminolevulinic acid (5-ALA) is a proagent developed for fluorescent-guided surgery for high-grade glioma patients associated with a significant increase in resection conferring survival. 5-ALA was shown to penetrate the blood–brain barrier accumulating in malignant glioma cells with h...
| Հիմնական հեղինակներ: | , , , , , , , , , , , |
|---|---|
| Ձևաչափ: | Հոդված |
| Լեզու: | English |
| Հրապարակվել է: |
BMJ Publishing Group
2022-07-01
|
| Շարք: | BMJ Open |
| Առցանց հասանելիություն: | https://bmjopen.bmj.com/content/12/7/e056059.full |